Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies.

MLA

Sung, Yun-Chieh, et al. “Delivery of Nitric Oxide with a Nanocarrier Promotes Tumour Vessel Normalization and Potentiates Anti-Cancer Therapies.” Nature Nanotechnology, vol. 14, no. 12, Dec. 2019, pp. 1160–69. EBSCOhost, https://doi.org/10.1038/s41565-019-0570-3.

APA

Sung, Y.-C., Jin, P.-R., Chu, L.-A., Hsu, F.-F., Wang, M.-R., Chang, C.-C., Chiou, S.-J., Qiu, J. T., Gao, D.-Y., Lin, C.-C., Chen, Y.-S., Hsu, Y.-C., Wang, J., Wang, F.-N., Yu, P.-L., Chiang, A.-S., Wu, A. Y.-T., Ko, J. J.-S., Lai, C. P.-K., … Chen, Y. (2019). Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies. Nature Nanotechnology, 14(12), 1160–1169. https://doi.org/10.1038/s41565-019-0570-3

Chicago

Sung, Yun-Chieh, Pei-Ru Jin, Li-An Chu, Fu-Fei Hsu, Mei-Ren Wang, Chih-Chun Chang, Show-Jen Chiou, et al. 2019. “Delivery of Nitric Oxide with a Nanocarrier Promotes Tumour Vessel Normalization and Potentiates Anti-Cancer Therapies.” Nature Nanotechnology 14 (12): 1160–69. doi:10.1038/s41565-019-0570-3.